Boehringer Ingelheim’s signal analytics technology acquired by ArisGlobal
ArisGlobal acquires Boehringer Ingelheim’s Benefit-Risk Analytic System (BRASS), a software solution designed to support causal analysis of drug safety data in a highly regulated environment